CDN $2.5 million of funding will support research into the potential utility of cannabis in addressing the overdose crisis.
Novel cannabinoid formulation, RAPID, is being tested for the treatment of stress and anxiety relief, cognitive focus, various kinds of pain and, migraines and could help curb opioid use.
U.S. Senate panel recognizes the need for America to begin stockpiling its industrial hemp genetics and funds new seed bank.
Revolutionary new test analyses fingerprint sweat to determine cocaine, opiates, amphetamines and cannabis use.
The patent-pending 130L extraction center is a powerhouse for continuous operation. Using ethanol as a solvent, the system will process approximately 35 pounds of material per hour with extremely high-quality output.